Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Jonathan R, Dalzell"'
Autor:
Sanjeet Avtaar Singh, Sudeep Das De, Karim Morcos, Yasser Hegazy, Hazim Al-Haideri, Jonathan R. Dalzell, Colin Berry, Harikrishna Doshi, Nawwar Al-Attar, Philip Curry
Publikováno v:
Experimental and Clinical Transplantation. 21:143-149
Autor:
Jonathan R. Dalzell
Publikováno v:
Circulation. 147:1489-1491
Autor:
Colin Berry, Nawwar Al-Attar, Ahmed Al-Adhami, Yasser Hegazy, Mark C. Petrie, Andrew Sinclair, Francesco Nappi, Sudeep Das De, Jonathan R. Dalzell, H. Doshi, Philip Curry, Sanjeet Singh Avtaar Singh
Publikováno v:
Journal of Thoracic Disease. 11:542-548
Background: There are 0.9 catheterization labs per 100,000 inhabitants in Scotland for percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), which are much less accessible to patients in remote and rural areas. An uncommon b
Autor:
Thomson, S, Julian, H, McLorinan, G, Verzin, E, Hamilton, A, Eames, N, Advanced Heart Failure Fellow, Alison I Smyth, Core Medical Trainee, Joanna Osmanska, Advanced Heart Failure Fellow, Stefanie Lip, Consultant Colorectal Surgeon, Peter S Chong, Consultant Cardiologist, Jonathan R Dalzell, McKenna, Caoimhe S., Znaczko, Anna, Morrison, Patrick J., Rana, Raafae, Saravanan, Amrita, Nizar, Hisham
Publikováno v:
The Ulster Medical Journal
Acute heart failure syndromes consist of a spectrum of clinical presentations due to impairment of some aspect of cardiac function. They represent a final common pathway for a vast array of pathologies, and may be either a de novo presentation or, mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28215f53ee8b9c2c2c24018fc7398c34
https://doi.org/10.1093/med/9780198849346.003.0047
https://doi.org/10.1093/med/9780198849346.003.0047
Autor:
Jonathan R. Dalzell, Kieran F. Docherty, Søren Lund Kristensen, Roy S Gardner, John R. Payne, Anna K. Barton, Ross T. Campbell, Jjv McMurray, Mark C. Petrie
Publikováno v:
European Heart Journal. 40
Background Estimated plasma volume (ePV) can be calculated from haematocrit and body weight, and has been shown to correlate with PV measured using 125Iodine labelled human serum albumin. Comparing a patient's ePV to ideal PV (iPV), an estimate of a
Publikováno v:
The New England journal of medicine. 381(5)
Publikováno v:
Heart Failure Reviews
Primary graft dysfunction (PGD) remains the leading cause of early mortality post-heart transplantation. Despite improvements in mechanical circulatory support and critical care measures, the rate of PGD remains significant. A recent consensus statem
Autor:
Caroline Haig, Mark C. Petrie, Paul Welsh, David Preiss, Ioannis K. Tsorlalis, Alex McConnachie, John J.V. McMurray, Naveed Sattar, Stefan D. Anker, Colette E. Jackson, Roy S. Gardner, Jonathan R. Dalzell
Publikováno v:
European Journal of Heart Failure. 18:1491-1498
Aims: In recent years there has been an increase in the number of biomarkers in heart failure ( HF ). The clinical role for these novel biomarkers in combination is not clear. Methods and results: The following novel biomarkers were measured from 628
Publikováno v:
Journal of the American College of Cardiology. 76:1912
Rowin et al. ([1][1]) provided a significant addition to the published data on advanced heart failure in patients with hypertrophic cardiomyopathy (HCM). Thankfully, such patients represent a small minority within the spectrum of HCM patients, but th